Therapeutic Approach of Histamine H3 Receptors in Obesity
Book:
Frontiers in CNS Drug Discovery
Page:
537-542
Author(s):
Takayuki Masaki and Hironobu Yoshimatsu
The Hypothalamus and Obesity
Book:
Frontiers in CNS Drug Discovery
Page:
519-536
Author(s):
Joanne A. Harrold and Jason C.G. Halford
The Quest to Repair the Damaged Spinal Cord
Book:
Frontiers in CNS Drug Discovery
Page:
497-518
Author(s):
Maria Teresa Moreno-Flores and Jesus Avila
Functional Interference of Dexamethasone on Some Morphine Effects: Hypothesis for the Steroid-Opioid Interaction: An Updated
Book:
Frontiers in CNS Drug Discovery
Page:
459-496
Author(s):
Anna Capasso, Mariella Caputo, Mario Felice Tecce and Alberto Loizzo
Neurokinin 3 (NK3) Receptor Modulators for the Treatment of Psychiatric Disorders
Book:
Frontiers in CNS Drug Discovery
Page:
430-458
Author(s):
Paul W. Smith and Lee A. Dawson
Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism
Book:
Frontiers in CNS Drug Discovery
Page:
413-429
Author(s):
Gabriel Barreda-Gomez and Rafael Rodriguez-Puertas
GPCR Drug Pipeline: New Compounds for CNS Diseases
Book:
Frontiers in CNS Drug Discovery
Page:
400-412
Author(s):
William K. Lim
The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in CNS Disorders
Book:
Frontiers in CNS Drug Discovery
Page:
390-399
Author(s):
Rafael Roesler, Flavio Kapczinski, Joao Quevedo, Felipe Dal Pizzol and Gilberto Schwartsmann
Tachykinergic System and Binding Molecules in Disease: Implication for Targeted Therapies
Book:
Frontiers in CNS Drug Discovery
Page:
378-389
Author(s):
Pranela Rameshwar
Muscarinic Acetylcholine Receptors as Novel Therapeutic Targets
Book:
Frontiers in CNS Drug Discovery
Page:
362-377
Author(s):
Ada Maria Tata